Gene therapy trial aims to halt kidney disease in High-Risk patients
Disease control
Recruiting now
This study tests a new gene therapy called PS-002 for adults with IgA nephropathy, a kidney disease that can lead to kidney failure. The treatment is given once and aims to control the disease in people who are at high risk of getting worse despite current treatments. The study w…
Phase: PHASE1, PHASE2 • Sponsor: Purespring Therapeutics Limited • Aim: Disease control
Last updated May 04, 2026 16:20 UTC